Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial

syn60244968

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.48105/CTF.2023-04-004.pc.gr.188710
studyName: Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial
dataStatus: Under Embargo
initiative: Contract Award
studyLeads: Yemima Berman
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1752451200000
institutions: University of Sydney, Australia
clinicalTrial: anzctr:ACTRN12618002021257
fundingAgency: CTF
manifestation: Quality of Life
embargoEndDate: 1755129600000
grantStartDate: 1702598400000
studyFileviewId: syn60244975
syn60244969
syn60504138
syn60244970
syn60244975
syn68522253
syn60244971
syn62012110

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial page is loading…

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial

syn60244968

Drop files to upload

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial page is loading…